Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, January 3, 2023
[ Tue, Jan 03rd 2023
] - WOPRAI
[ Tue, Jan 03rd 2023
] - WOPRAI
[ Tue, Jan 03rd 2023
] - WOPRAI
[ Tue, Jan 03rd 2023
] - WOPRAI
[ Tue, Jan 03rd 2023
] - WOPRAI
[ Tue, Jan 03rd 2023
] - WOPRAI
[ Tue, Jan 03rd 2023
] - WOPRAI
[ Tue, Jan 03rd 2023
] - WOPRAI
[ Tue, Jan 03rd 2023
] - WOPRAI
[ Tue, Jan 03rd 2023
] - WOPRAI
[ Tue, Jan 03rd 2023
] - WOPRAI
[ Tue, Jan 03rd 2023
] - WOPRAI
[ Tue, Jan 03rd 2023
] - WOPRAI
[ Tue, Jan 03rd 2023
] - WOPRAI
[ Tue, Jan 03rd 2023
] - WOPRAI
[ Tue, Jan 03rd 2023
] - WOPRAI
[ Tue, Jan 03rd 2023
] - WOPRAI
[ Tue, Jan 03rd 2023
] - WOPRAI
[ Tue, Jan 03rd 2023
] - WOPRAI
[ Tue, Jan 03rd 2023
] - WOPRAI
[ Tue, Jan 03rd 2023
] - WOPRAI
[ Tue, Jan 03rd 2023
] - WOPRAI
[ Tue, Jan 03rd 2023
] - WOPRAI
[ Tue, Jan 03rd 2023
] - WOPRAI
[ Tue, Jan 03rd 2023
] - WOPRAI
[ Tue, Jan 03rd 2023
] - WOPRAI
[ Tue, Jan 03rd 2023
] - WOPRAI
[ Tue, Jan 03rd 2023
] - WOPRAI
Fri, December 30, 2022
[ Fri, Dec 30th 2022
] - WOPRAI
Mayank Mamtani Maintained (TGTX) at Strong Buy with Increased Target to $23 on, Dec 30th, 2022
Mayank Mamtani of B. Riley Securities, Maintained "TG Therapeutics, Inc." (TGTX) at Strong Buy with Increased Target from $17 to $23 on, Dec 30th, 2022.
Mayank has made no other calls on TGTX in the last 4 months.
There are 2 other peers that have a rating on TGTX. Out of the 2 peers that are also analyzing TGTX, 0 agree with Mayank's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Mayank
- Alec Stranahan of "B of A Securities" Maintained at Sell with Increased Target to $6 on, Thursday, December 29th, 2022
- Edward White of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $24 on, Thursday, December 29th, 2022
